https://box5peptide.com/your-r....na-binding-health-pr
Our findings, stemming from the analysis, showed a link between the OAR dose and the potential for moderate to severe dysphagia and dysgeusia, thereby prompting the proposal of new dose restrictions for PCM (367Gy) and the oral cavity (205Gy). The investigation into OAR dose demonstrated an association with the risk of developing moderate to severe dysphagia and dysgeusia, resulting in revised dose guidelines for PCM (367Gy) and oral cavity (205Gy). Examining how vi
Like
Comment
Share
